| Literature DB >> 28101372 |
Marie Vidailhet1, Emmanuel Roze2, Lucie Maugest3, Cécile Gallea4.
Abstract
BACKGROUND: Primary orthostatic tremor is a rare disorder that is still under-diagnosed or misdiagnosed. Motor symptoms are fairly characteristics but the real impact on the patient's every day life and quality of life is under-estimated. The "how my patients taught me" format describes the impact on the patients' every day life with their own words, which is rarely done. CASEEntities:
Year: 2017 PMID: 28101372 PMCID: PMC5234118 DOI: 10.1186/s40734-016-0048-5
Source DB: PubMed Journal: J Clin Mov Disord ISSN: 2054-7072
Characteristics of primary orthostatic tremor
| Motor features | Non motor features | Electrophysiological & neuro-imaging findings |
|---|---|---|
| Lower body tremor activated on standing position | Fear of falling | Tremor frequency 13–18 Hz (high inter-muscular coherence) |
| Tremor absent when sitting and lying | Pain | Brain neuroimaging (MRI) normal range |
| Primarily affects the legs and trunk | Anxiety | Normal DAT scan |
| Unsteadiness while standing | Social phobia | |
| Urge to search support to feel stable | ||
| Worsening over time (same tremor frequency, increased amplitude) | Alteration of attention, executive function, visuospatial ability, & visual memory (>60 y.o.) |
MRI magnetic resonance imaging, DAT scan dopamine transporter imaging, y.o. years-old
Treatment options in primary orthostatic tremor
| Drugs/Neurostimulation | Doses | Reported clinical effect |
|---|---|---|
| Clonazepam | 0.5 mg- 6 mg /day | Moderate to marked benefit in 50 to 30% of the patients |
| Gabapentin | 300–2400 mg/day | Moderate to marked benefit |
| Beta-blockers (propranolol | 20–240 mg/day | Little effect of POT. May improve arm postural tremor |
| Primidone | 125–250 mg/day | No effect, poor tolerance |
| L-Dopa Pramipexolea | 300–800 mg/day | Rare cases (short term benefit)b |
| Antiepileptic drugs (valproic acid, phenobarbital, carbamazepine, levetiracetam, topiramate, pregabalin) | Minimal to no effect | |
|
cDeep Brain stimulation | Thalamusc | Rare cases. Variable results. Some increase in time in the upright position. |
| Botulinum toxin (tibial anterior) | No beneficial effect |
PD Parkinson’s disease
aAnecdotal effect of pramipexole bL-Dopa or pramipexole may help in slow orthostatic tremor in Parkinson’s disease, little or no benefit on POT preceding or associated with PD. cDeep brain stimulation of the thalamus (Ventral intermediate nucleus Vim) same target as in Essential Tremor
Secondary orthostatic tremors
| Associated clinical features neuro-imaging abnormalities | High/slowtremor frequency | Neurological disorders |
|---|---|---|
| Parkinsonism, gait difficulty, postural instability | Slow 6–7 Hz tremor | Acqueduc stenosis |
| Truncal ataxia, cranial nerve involvement | Fast orthostatic tremor (15 Hz) | Pontine lesions/midbrain lesions |
| Broad based ataxic gait, cerebellar tremor, dysmetria, speech involvement, saccadic pursuit, dysmetria of saccades | From fast 14–15 Hz tremor to the lower range of OT (13 Hz tremor) | Cerebellar degeneration, Spino-cerebellar ataxia (genetic, e.g. SCA2) |
| Ataxia, sensory disturbances, pyramidal signs, relapsing remitting/progressive | Very slow 4 Hz tremor | Multiple sclerosis |
| Postural instability, urinary symptoms | 14–13 Hz | Spinal cord lesion |
| Sensory disturbances, mild weakness of the upper limbs, postural tremor | 6–7 Hz | Neuropathy (IgG and IgA gammapathy or polyradiculopathy, paraneoplasic disorders |
Rare cases of orthostatic tremor have been reported with dopamine blocker agents (neuroleptics), vitamin B12 deficiency (same frequency as POT°, spastic paraparesis (16 Hz), stiff-person and Graves disease